Up-regulation of P2X7 receptor-mediated inhibition of GABA uptake by nerve terminals of the human epileptic neocortex
- PMID: 26714441
- DOI: 10.1111/epi.13263
Up-regulation of P2X7 receptor-mediated inhibition of GABA uptake by nerve terminals of the human epileptic neocortex
Abstract
Objective: Thirty percent of patients with epilepsy are refractory to medication. The majority of these patients have mesial temporal lobe epilepsy (MTLE). This prompts for new pharmacologic targets, like ATP-mediated signaling pathways, since the extracellular levels of the nucleotide dramatically increase during in vitro epileptic seizures. In this study, we investigated whether sodium-dependent high-affinity γ-aminobutyric acid (GABA) and glutamate uptake by isolated nerve terminals of the human neocortex could be modulated by ATP acting via slow-desensitizing P2X7 receptor (P2X7R).
Methods: Modulation of [(3) H]GABA and [(14) C]glutamate uptake by ATP, through activation of P2X7R, was investigated in isolated nerve terminals of the neocortex of cadaveric controls and patients with drug-resistant epilepsy (non-MTLE or MTLE) submitted to surgery. Tissue density and distribution of P2X7R in the human neocortex was assessed by Western blot analysis and immunofluorescence confocal microscopy.
Results: The P2X7R agonist, 2'(3')-O-(4-benzoylbenzoyl)ATP (BzATP, 3-100 μm) decreased [(3) H]GABA and [(14) C]glutamate uptake by nerve terminals of the neocortex of controls and patients with epilepsy. The inhibitory effect of BzATP (100 μm) was prevented by the selective P2X7R antagonist, A-438079 (3 μm). Down-modulation of [(14) C]glutamate uptake by BzATP (100 μm) was roughly similar in controls and patients with epilepsy, but the P2X7R agonist inhibited more effectively [(3) H]GABA uptake in the epileptic tissue. Neocortical nerve terminals of patients with epilepsy express higher amounts of the P2X7R protein than control samples.
Significance: High-frequency cortical activity during epileptic seizures releases huge amounts of ATP, which by acting on low-affinity slowly desensitizing ionotropic P2X7R, leads to down-modulation of neuronal GABA and glutamate uptake. Increased P2X7R expression in neocortical nerve terminals of patients with epilepsy may, under high-frequency firing, endure GABA signaling and increase GABAergic rundown, thereby unbalancing glutamatergic neuroexcitation. This study highlights the relevance of the ATP-sensitive P2X7R as an important negative modulator of GABA and glutamate transport and prompts for novel antiepileptic therapeutic targets.
Keywords: Epilepsy; GABA; Glutamate; High-affinity transporters; MTLE; P2X7R.
Wiley Periodicals, Inc. © 2015 International League Against Epilepsy.
Similar articles
-
Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor.Int J Mol Sci. 2022 Feb 21;23(4):2380. doi: 10.3390/ijms23042380. Int J Mol Sci. 2022. PMID: 35216493 Free PMC article. Review.
-
P2X7 receptor activation downmodulates Na(+)-dependent high-affinity GABA and glutamate transport into rat brain cortex synaptosomes.Neuroscience. 2015 Oct 15;306:74-90. doi: 10.1016/j.neuroscience.2015.08.026. Epub 2015 Aug 20. Neuroscience. 2015. PMID: 26299340
-
Under stressful conditions activation of the ionotropic P2X7 receptor differentially regulates GABA and glutamate release from nerve terminals of the rat cerebral cortex.Neurochem Int. 2018 Jan;112:81-95. doi: 10.1016/j.neuint.2017.11.005. Epub 2017 Nov 14. Neurochem Int. 2018. PMID: 29154812
-
Mesial Temporal Lobe Epilepsy (MTLE) Drug-Refractoriness Is Associated With P2X7 Receptors Overexpression in the Human Hippocampus and Temporal Neocortex and May Be Predicted by Low Circulating Levels of miR-22.Front Cell Neurosci. 2022 Jul 7;16:910662. doi: 10.3389/fncel.2022.910662. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35875355 Free PMC article.
-
The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory Epilepsy.Int J Mol Sci. 2024 Jun 23;25(13):6894. doi: 10.3390/ijms25136894. Int J Mol Sci. 2024. PMID: 39000004 Free PMC article. Review.
Cited by
-
Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor.Int J Mol Sci. 2022 Feb 21;23(4):2380. doi: 10.3390/ijms23042380. Int J Mol Sci. 2022. PMID: 35216493 Free PMC article. Review.
-
Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease.Purinergic Signal. 2025 Feb;21(1):149-177. doi: 10.1007/s11302-024-10034-x. Epub 2024 Jul 24. Purinergic Signal. 2025. PMID: 39046648 Free PMC article. Review.
-
Major depressive disorder: hypothesis, mechanism, prevention and treatment.Signal Transduct Target Ther. 2024 Feb 9;9(1):30. doi: 10.1038/s41392-024-01738-y. Signal Transduct Target Ther. 2024. PMID: 38331979 Free PMC article. Review.
-
Synaptic Reshaping and Neuronal Outcomes in the Temporal Lobe Epilepsy.Int J Mol Sci. 2021 Apr 8;22(8):3860. doi: 10.3390/ijms22083860. Int J Mol Sci. 2021. PMID: 33917911 Free PMC article. Review.
-
Silencing epileptic storms: targeting miRNA-lncRNA crosstalk in astrocytes and microglia to disarm neuroinflammatory triggers.Front Mol Neurosci. 2025 Jul 28;18:1616804. doi: 10.3389/fnmol.2025.1616804. eCollection 2025. Front Mol Neurosci. 2025. PMID: 40791576 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical